SCHEMBL4540145

SCHEMBL4540145

COC(=O)c1cccn1-c1ncc(F)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPT P10636 7/20 0.46
NPSR1 Q6W5P4 2/20 0.46
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PPARG P37231 1/20 0.44
NR2E3 Q9Y5X4 1/20 0.44
NCOR2 Q9Y618 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.38
P2RY12 Q9H244 1/20 0.38
ALDH1A1 P00352 2/20 0.38
HPGD P15428 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
OPRK1 P41145 1/20 0.38
PKM P14618 1/20 0.38
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4540046 0.85 MAPT (0.43) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4539989 0.85 MAPT (0.43) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4539690 0.85 MAPT (0.51) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4540292 0.84 MAPT (0.64) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4542687 0.81 MAPT (0.45) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4540140 0.74 MAPT (0.50) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
Acetonitrile SCHEMBL27922454 0.74 BDKRB1 (0.40) MAPTMEN1KMT2APPARGNR2E3
SCHEMBL4542880 0.74 CYP2C9 (0.58) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL27857191 0.73 KMT2A (0.43) CYP1A2CYP3A4CYP2C9CYP2C19MAPT
SCHEMBL4542793 0.72 BDKRB1 (0.44) CYP1A2CYP3A4CYP2C9CYP2C19MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010523-A1 SPIROCOMPOUNDS USEFUL AS MODULATORS FOR DOPAMINE D3 RECEPTORS GLAXO GROUP LIMITED (GB) 2009-01-07 EP claimed
WO-2007125061-A1 SPIROCOMPOUNDS USEFUL AS MODULATORS FOR DOPAMINE D3 RECEPTORS GLAXO GROUP LIMITED (GB) 2007-11-08 WO claimed
WO-2009117421-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2009-09-24 WO disclosed